News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Progenics Pharmaceuticals, Inc. (PGNX) CEO, Mark R. Baker, To Present At 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference


2/7/2014 9:04:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TARRYTOWN, N.Y., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (PGNX), an oncology company focused on the development of innovative approaches to targeting and treating cancer, announced today that Mark R. Baker, CEO of Progenics, will present at the 16th Annual BIO CEO & Investor Conference which will be held February 10th and 11th at the Waldorf Astoria Hotel in New York City. The presentation will take place on Monday, February 10th at 3:00 PM EST.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES